Furthermore, IFNγ upregulated the expression of several anti-apoptotic proteins, including MCL1, PARP9, and PARP14, both in untreated and imatinib-treated primary human CD34+ CML stem/progenitor cells. The gene discussed is MCL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.